News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
About
Partnerships

|Videos|January 5, 2023

Impact of Routes of Administration on Contraceptive Adherence

Author(s)Jenna Beckham, MD, MSPH, FACOG, Thomas Kimble, MD

Jenna Beckham, MD, MSPH, FACOG, and Thomas Kimble, MD, discuss patient misconceptions around contraceptive options and the impact on adherence.

Episodes in this series

EP. 1 Prevalence of Contraceptive Use in the US

EP. 1 Prevalence of Contraceptive Use in the US

EP. 2 Initiating Contraception Conversations With Patients

EP. 2 Initiating Contraception Conversations With Patients

EP. 3 Communicating With Patients About Contraceptives

EP. 3 Communicating With Patients About Contraceptives

EP. 4 Role of Pharmacists and Other Healthcare Professionals in Contraceptive Counseling

EP. 4 Role of Pharmacists and Other Healthcare Professionals in Contraceptive Counseling

EP. 5 Use of Hormonal Contraceptive Agents

EP. 5 Use of Hormonal Contraceptive Agents

EP. 6 Contraception for Patients With Higher BMI

EP. 6 Contraception for Patients With Higher BMI

EP. 7 Cardiovascular Risks Associated With Contraceptive Use

EP. 7 Cardiovascular Risks Associated With Contraceptive Use

EP. 8 Overview of Approved Contraceptives: Drospirenone

EP. 8 Overview of Approved Contraceptives: Drospirenone

EP. 9 Additional Methods of Contraception

EP. 9 Additional Methods of Contraception

EP. 10 Hormonal Patch and Vaginal Gel Contraceptives

EP. 10 Hormonal Patch and Vaginal Gel Contraceptives

EP. 11 Impact of Routes of Administration on Contraceptive Adherence

EP. 11 Impact of Routes of Administration on Contraceptive Adherence

EP. 12 Benefits of Recently Approved Contraceptives

EP. 12 Benefits of Recently Approved Contraceptives

EP. 13 Educational Resources on Contraceptive Options

EP. 13 Educational Resources on Contraceptive Options

EP. 14 Unmet Needs in Contraception

EP. 14 Unmet Needs in Contraception

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related Content

Jeffrey Jensen, MD, contextualizes contraceptive efficacy in modern trials

ByJoshua Fitch, Senior Editor ,Jeffrey Jensen, MD, MPH

August 4th 2026

Jeffrey Jensen, MD, MPH, welcomes the newly approved Gwyn Lo contraceptive patch as an expanded, low-estrogen option for patients seeking a once-weekly method.

Jeffrey Jensen, MD, reacts to FDA approval of new contraception patch, Gwyn Lo

ByJoshua Fitch, Senior Editor ,Jeffrey Jensen, MD, MPH

August 3rd 2026

FDA approves norelgestromin and ethinyl estradiol transdermal patch for contraception

FDA approves norelgestromin and ethinyl estradiol transdermal patch for contraception

ByJoshua Fitch, Senior Editor

July 29th 2026

Contemporary OB/GYN's top stories from the first half of 2026 | Image credit: Stock.adobe.com

Contemporary OB/GYN's top stories from the first half of 2026

ByJoshua Fitch, Senior Editor

July 1st 2026

5 women's health FDA headlines you missed in Q2 2026| Image credit: Contemporary OB/GYN

5 women's health FDA headlines you missed in Q2 2026

ByJoshua Fitch, Senior Editor

June 29th 2026

Latest CME

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Case-based Simulation

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Rachel N. Grisham, MD

Trending on Contemporary OB/GYN

ACOG's New Guidance on Diagnosing Endometriosis Without Surgery

Why Endometriosis Diagnosis Is Often Delayed by a Decade

FDA clears Revi Extend implant for urgency urinary incontinence

Urinalysis for the ob-gyn: Advanced interpretation, when to refer, and underappreciated parameters

Alex Peahl, MD, MSc, on the feasibility of patient-operated remote biophysical profiles